Veerhealth Care Ltd
Veerhealth Care Ltd (VEERHEALTH): company summary
The company's business has improved significantly, with annual revenue rising 94.8% and annual net profit increasing 38.5%.
Veerhealth Care Ltd (VEERHEALTH) is a micro-cap Healthcare company valued at ₹98 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Veerhealth Care Ltd last traded at ₹49.73, modestly up 0.08% on the day.
- Financial performance
- The company's business has improved significantly, with annual revenue rising 94.8% and annual net profit increasing 38.5%. However, the net profit margin narrowed to 1.7% from 2.3% in the prior year, and return on equity remained low at 2.4%. The latest quarter saw revenue surge 455.2% and net profit jump 412.5% compared to the same quarter a year earlier.
- Valuation multiples
- The stock trades at 184.2 times earnings, a premium to the Healthcare median of 32.0, 4.36 times book value.
- Things to watch
- The company's profit growth has slowed, with a 30.1% decline in 3-year profit CAGR and a 7.3% increase in 5-year profit CAGR. The net profit margin has fallen by 0.7 percentage points, and the company's return on capital employed is only 6.0%. The stock is 4.4% below its 52-week high.
- Where it stands
- Veerhealth Care Ltd has seen strong revenue growth, but profit growth has been inconsistent. The latest quarter showed a sharp rise in both revenue and net profit, but the net profit margin remains low. The stock is currently 4.4% below its 52-week high.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by momentum (7.5) and risk (6.3), but held back by valuation (0.0). Momentum looks strong at 7.5, but that is offset by valuation at 0.0 and quality at 2.9. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Low leverage — D/E 0.20
- Revenue compounding 25% a year
- Valuation is weak (0.0/10)
- Expensive at 184× earnings
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Veerhealth Care Ltd’s valuation
Free deep-dive tools · no sign-up
Veerhealth Care Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Veerhealth Care Ltd with peers
Related tools & concepts
Value Veerhealth Care Ltd with the ratios and calculators DocStoX uses in its analysis.

